Abiopharma

Ceased to be an interested party - Meitav Investment House Ltd.

KRTL Holding Group Announces RAYEL and PERIKO Coca-Derived Extract Platform for Beverage and Pharmaceutical API Development

Trustee report to the BONDS (Series 4) holders during the period from 24.6.25 until its final maturity date - Hermetic

Net Asset Value(s)

Xometry Expands Injection Molding Platform with a Wider Selection of Materials, On-Demand Expert Access and One-Click Reordering

Odysight.ai® Receives Purchase Order from Honeywell Aerospace APU Division to Launch Proof of Concept of Odysight.ais Advanced Predictive Maintenance Vision-Based Monitoring System on Honeywell Aerospace Auxiliary Power Units Portfolio

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease

Social Media Is Now the Primary Channel for Brand Crisis Response, New Research Finds